RYLD ETF

RYLD ETF
$15.20
See how much of RYLD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 11 of 11 holdings · as of Oct 2, 2026
RYLD holdings, by weight
#TickerNameWeightCumulativeSharesMkt value
1
RSSL
Global X Russell 2000 Etf
100.55%		100.5%12,057,924$1.33B
2—Other Payable & Receivables
0.33%		100.9%4,291,204$4.29M
3—Cash
0.08%		101.0%1,067,364$1.07M
4—Inhibrx Inc
0.00%		101.0%15,798$10.3K
5—Cartesian Therapeutics Inc
0.00%		101.0%1-
6—Omniab Inc - 15.00 Earnout
0.00%		101.0%2,421-
7—CAD
0.00%		101.0%7,088$5.0K
8—Novartis Ag - Cvr
0.00%		101.0%26,043$10.2K
9—Omniab Inc - 12.5 Earnout
0.00%		101.0%2,421-
10
RAIN
Rain Oncology Inc
0.00%		101.0%1-
11—Rut US 10/16/26 C2855
-0.96%		100.0%-4,686$-12699060
Not reported for this fund: share changes, sector, industry.

RYLD ETF All Holdings

RYLD holdings total 12 positions. The top 10 holdings account for 101.0% of the fund, led by Global X Russell 2000 Etf at 100.5%, Other Payable & Receivables at 0.3%, Cash at 0.1%.

RYLD portfolio concentration is relatively high, with the top 10 representing 101.0% of total assets.

RYLD sectors provide a detailed breakdown. RYLD overlap shows how holdings compare to other funds in your portfolio.

Compare RYLD

RYLD vs SPYRYLD vs QQQRYLD vs VOORYLD vs VTIRYLD vs IVVRYLD vs SCHDRYLD vs VYMRYLD vs VXUS

RYLD ETF Holdings

11 of 12 holdings

  • 1

    Global X Russell 2000 Etf

    RSSLUnknown
    100.55%
  • 2

    Other Payable & Receivables

    Other
    0.33%
  • 3

    Cash

    Other
    0.08%
  • 4

    Inhibrx Inc

    INBXUnknown
    0.00%
  • 5

    Cartesian Therapeutics Inc

    RNACUnknown
    0.00%
  • 6

    OMNIAB INC - 15.00 EARNOUT

    Other
    0.00%
  • 7

    CAD

    Other
    0.00%
  • 8

    Novartis Ag - Cvr

    Other
    0.00%
  • 9

    Omniab Inc - 12.5 Earnout

    OABIUnknown
    0.00%
  • 10

    Rain Oncology Inc

    RAINUnknown
    0.00%
  • 11

    RUT US 10/16/26 C2855

    Other
    -0.96%